426 related articles for article (PubMed ID: 36607488)
1. Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines.
Ou B; Yang Y; Lv H; Lin X; Zhang M
BioDrugs; 2023 Mar; 37(2):143-180. PubMed ID: 36607488
[TBL] [Abstract][Full Text] [Related]
2. Developments in Vaccine Adjuvants.
Firdaus FZ; Skwarczynski M; Toth I
Methods Mol Biol; 2022; 2412():145-178. PubMed ID: 34918245
[TBL] [Abstract][Full Text] [Related]
3. Research progress in the development of natural-product-based mucosal vaccine adjuvants.
Gao Y; Guo Y
Front Immunol; 2023; 14():1152855. PubMed ID: 37090704
[TBL] [Abstract][Full Text] [Related]
4. Development of thermostable vaccine adjuvants.
Qi Y; Fox CB
Expert Rev Vaccines; 2021 May; 20(5):497-517. PubMed ID: 33724133
[TBL] [Abstract][Full Text] [Related]
5. Advances and challenges in mucosal adjuvant technology.
Newsted D; Fallahi F; Golshani A; Azizi A
Vaccine; 2015 May; 33(21):2399-405. PubMed ID: 25865473
[TBL] [Abstract][Full Text] [Related]
6. Vaccine adjuvants: mechanisms and platforms.
Zhao T; Cai Y; Jiang Y; He X; Wei Y; Yu Y; Tian X
Signal Transduct Target Ther; 2023 Jul; 8(1):283. PubMed ID: 37468460
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Adjuvants: Selection Criteria, Mechanism of Action Associated with Immune Responses and Future Directions.
Habib A; Anjum KM; Iqbal R; Jaffar G; Ashraf Z; Khalid MS; Taj MU; Zainab SW; Umair M; Zohaib M; Khalid T
Iran J Immunol; 2023 Mar; 20(1):1-15. PubMed ID: 36917475
[TBL] [Abstract][Full Text] [Related]
8. In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives.
Zeng Y; Zou F; Xia N; Li S
Expert Rev Vaccines; 2023; 22(1):681-695. PubMed ID: 37496496
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants.
Hioki K; Hayashi T; Natsume-Kitatani Y; Kobiyama K; Temizoz B; Negishi H; Kawakami H; Fuchino H; Kuroda E; Coban C; Kawahara N; Ishii KJ
Front Immunol; 2022; 13():847616. PubMed ID: 35663999
[TBL] [Abstract][Full Text] [Related]
10. Laser vaccine adjuvants: Light-augmented immune responses.
Maki Y; Kashiwagi S; Kimizuka Y
Vaccine; 2021 Nov; 39(46):6805-6812. PubMed ID: 34666921
[TBL] [Abstract][Full Text] [Related]
11. Potentials of saponins-based adjuvants for nasal vaccines.
Chen K; Wang N; Zhang X; Wang M; Liu Y; Shi Y
Front Immunol; 2023; 14():1153042. PubMed ID: 37020548
[TBL] [Abstract][Full Text] [Related]
12. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
13. Materials engineering strategies for cancer vaccine adjuvant development.
Zhang X; Yang B; Ni Q; Chen X
Chem Soc Rev; 2023 May; 52(9):2886-2910. PubMed ID: 37014050
[TBL] [Abstract][Full Text] [Related]
14. New-age vaccine adjuvants, their development, and future perspective.
Verma SK; Mahajan P; Singh NK; Gupta A; Aggarwal R; Rappuoli R; Johri AK
Front Immunol; 2023; 14():1043109. PubMed ID: 36911719
[TBL] [Abstract][Full Text] [Related]
15. Adjuvants for human vaccines--current status, problems and future prospects.
Gupta RK; Siber GR
Vaccine; 1995 Oct; 13(14):1263-76. PubMed ID: 8585280
[TBL] [Abstract][Full Text] [Related]
16. Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants.
Liu Z; Hosomi K; Kunisawa J
Vaccine; 2022 Aug; 40(36):5399-5403. PubMed ID: 35918205
[TBL] [Abstract][Full Text] [Related]
17. Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions.
Cao LM; Yu YF; Li ZZ; Zhong NN; Wang GR; Xiao Y; Liu B; Wu QJ; Feng C; Bu LL
J Nanobiotechnology; 2024 Jun; 22(1):308. PubMed ID: 38825711
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulant plant proteins: Potential candidates as vaccine adjuvants.
Nazeam JA; Singab ANB
Phytother Res; 2022 Dec; 36(12):4345-4360. PubMed ID: 36128599
[TBL] [Abstract][Full Text] [Related]
19. What are the limits of adjuvanticity?
Del Giudice G; Podda A; Rappuoli R
Vaccine; 2001 Oct; 20 Suppl 1():S38-41. PubMed ID: 11587808
[TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvants: current status, research and development, licensing, and future opportunities.
Cui Y; Ho M; Hu Y; Shi Y
J Mater Chem B; 2024 May; 12(17):4118-4137. PubMed ID: 38591323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
